| Dr Elton Timothy Shapiro, MD | |
|
2801 Ne 213th St Ste 1015, Aventura, FL 33180-1266 | |
| (305) 937-3000 | |
| (888) 268-0675 |
| Full Name | Dr Elton Timothy Shapiro |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 46 Years |
| Location | 2801 Ne 213th St Ste 1015, Aventura, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275551442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | ME58021 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aventura Hospital And Medical Center | Aventura, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aventura Endocrine Associates Pa | 5799726238 | 2 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Can pyruvate, the end product of glycolysis, help improve cardiovascular function in children who have cardiopulmonary bypass surgery and suffer from low cardiac output syndrome? This question is one that Rafael Jaimes, Ph.D., a staff scientist at Children's National Heart Institute, a division of Children's National Health System, is studying, thanks to a two-year grant from the American Heart Association.
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent.
Exercise training is safe in heart failure patients, does not significantly reduce hospitalization or death, but is associated with several improved clinical outcomes, even in those already receiving optimal medical care, researchers reported at the American Heart Association's Scientific Sessions 2008. The Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was presented as a late-breaking clinical trial.
› Verified 6 days ago
| Entity Name | Aventura Endocrine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720001191 PECOS PAC ID: 5799726238 Enrollment ID: O20050516000480 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Can pyruvate, the end product of glycolysis, help improve cardiovascular function in children who have cardiopulmonary bypass surgery and suffer from low cardiac output syndrome? This question is one that Rafael Jaimes, Ph.D., a staff scientist at Children's National Heart Institute, a division of Children's National Health System, is studying, thanks to a two-year grant from the American Heart Association.
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent.
Exercise training is safe in heart failure patients, does not significantly reduce hospitalization or death, but is associated with several improved clinical outcomes, even in those already receiving optimal medical care, researchers reported at the American Heart Association's Scientific Sessions 2008. The Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was presented as a late-breaking clinical trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elton Timothy Shapiro, MD 2801 Ne 213th St Ste 1015, Aventura, FL 33180-1266 Ph: (305) 937-3000 | Dr Elton Timothy Shapiro, MD 2801 Ne 213th St Ste 1015, Aventura, FL 33180-1266 Ph: (305) 937-3000 |
News Archive
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
Can pyruvate, the end product of glycolysis, help improve cardiovascular function in children who have cardiopulmonary bypass surgery and suffer from low cardiac output syndrome? This question is one that Rafael Jaimes, Ph.D., a staff scientist at Children's National Heart Institute, a division of Children's National Health System, is studying, thanks to a two-year grant from the American Heart Association.
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent.
Exercise training is safe in heart failure patients, does not significantly reduce hospitalization or death, but is associated with several improved clinical outcomes, even in those already receiving optimal medical care, researchers reported at the American Heart Association's Scientific Sessions 2008. The Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was presented as a late-breaking clinical trial.
› Verified 6 days ago
Mr. Solomon Leo Lerer, M.D., F.A.C.G., Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, # 303, Aventura, FL 33180 Phone: 305-931-6220 Fax: 305-466-4755 | |
Dr. David Yitzchok Manela, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2820 Ne 214th St Ste 902, Aventura, FL 33180 Phone: 213-509-5115 | |
Dr. Steven Kobrin, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2801 Ne 213th St Ste 101, Aventura, FL 33180 Phone: 305-466-7333 Fax: 786-651-2177 | |
Luis Jorge Echarte, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 303, Aventura, FL 33180 Phone: 305-466-0030 Fax: 305-466-4755 | |
Nelson Perez Mateu, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20601 E Dixie Hwy Ste 340, Aventura, FL 33180 Phone: 786-923-4000 | |
Leonard J Pianko, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 21097 Ne 27th Ct Ste 110, Aventura, FL 33180 Phone: 305-384-4720 Fax: 305-933-1749 | |
Jay E Reinberg, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2845 Aventura Blvd, Suite 247, Aventura, FL 33180 Phone: 305-932-9880 Fax: 305-932-1035 |